664 related articles for article (PubMed ID: 35331296)
1. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.
Jiang Y; Zhang H; Wang J; Liu Y; Luo T; Hua H
J Hematol Oncol; 2022 Mar; 15(1):34. PubMed ID: 35331296
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
Najafi M; Farhood B; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix remodeling in the tumor immunity.
Du W; Xia X; Hu F; Yu J
Front Immunol; 2023; 14():1340634. PubMed ID: 38332915
[TBL] [Abstract][Full Text] [Related]
4. Biological role of matrix stiffness in tumor growth and treatment.
Deng B; Zhao Z; Kong W; Han C; Shen X; Zhou C
J Transl Med; 2022 Nov; 20(1):540. PubMed ID: 36419159
[TBL] [Abstract][Full Text] [Related]
5. Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression.
Gehler S; Ponik SM; Riching KM; Keely PJ
Crit Rev Eukaryot Gene Expr; 2013; 23(2):139-57. PubMed ID: 23582036
[TBL] [Abstract][Full Text] [Related]
6. Sig1R activates extracellular matrix-induced bladder cancer cell proliferation and angiogenesis by combing β-integrin.
Zhao F; Yang T; Zhou L; Li R; Liu J; Zhao J; Jia R
Aging (Albany NY); 2023 May; 15(10):4182-4201. PubMed ID: 37199665
[TBL] [Abstract][Full Text] [Related]
7. Integrin control of tumor invasion.
Missan DS; DiPersio M
Crit Rev Eukaryot Gene Expr; 2012; 22(4):309-24. PubMed ID: 23272801
[TBL] [Abstract][Full Text] [Related]
8. Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment.
Niland S; Eble JA
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379400
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix and its therapeutic potential for cancer treatment.
Huang J; Zhang L; Wan D; Zhou L; Zheng S; Lin S; Qiao Y
Signal Transduct Target Ther; 2021 Apr; 6(1):153. PubMed ID: 33888679
[TBL] [Abstract][Full Text] [Related]
10. Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy.
Xiong J; Xiao R; Zhao J; Zhao Q; Luo M; Li F; Zhang W; Wu M
J Transl Med; 2024 Jan; 22(1):85. PubMed ID: 38246995
[TBL] [Abstract][Full Text] [Related]
11. The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies.
Wei J; Yao J; Yan M; Xie Y; Liu P; Mao Y; Li X
Acta Biomater; 2022 Sep; 150():34-47. PubMed ID: 35948177
[TBL] [Abstract][Full Text] [Related]
12. Tension in Cancer.
Löffek S; Franzke CW; Helfrich I
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854331
[TBL] [Abstract][Full Text] [Related]
13. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.
Yuan Z; Li Y; Zhang S; Wang X; Dou H; Yu X; Zhang Z; Yang S; Xiao M
Mol Cancer; 2023 Mar; 22(1):48. PubMed ID: 36906534
[TBL] [Abstract][Full Text] [Related]
14. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD
BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992
[TBL] [Abstract][Full Text] [Related]
15. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy.
Mai Z; Lin Y; Lin P; Zhao X; Cui L
Cell Death Dis; 2024 May; 15(5):307. PubMed ID: 38693104
[TBL] [Abstract][Full Text] [Related]
16. Beyond matrix stiffness: targeting force-induced cancer drug resistance.
Kalli M; Poskus MD; Stylianopoulos T; Zervantonakis IK
Trends Cancer; 2023 Nov; 9(11):937-954. PubMed ID: 37558577
[TBL] [Abstract][Full Text] [Related]
17. Tumor mechanics and metabolic dysfunction.
Tung JC; Barnes JM; Desai SR; Sistrunk C; Conklin MW; Schedin P; Eliceiri KW; Keely PJ; Seewaldt VL; Weaver VM
Free Radic Biol Med; 2015 Feb; 79():269-80. PubMed ID: 25532934
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion.
Keely PJ
J Mammary Gland Biol Neoplasia; 2011 Sep; 16(3):205-19. PubMed ID: 21822945
[TBL] [Abstract][Full Text] [Related]
19. Insidious changes in stromal matrix fuel cancer progression.
Miles FL; Sikes RA
Mol Cancer Res; 2014 Mar; 12(3):297-312. PubMed ID: 24452359
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated microRNAs and long non-coding RNAs associated with extracellular matrix stiffness.
Qiu H; Fu Y; Guo Z; Zhang X; Wang X; Wu H
Exp Cell Res; 2024 Apr; 437(2):114014. PubMed ID: 38547959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
